# ADAPT Transcatheter Aortic Valve Intervention (TAVI & Chronic Total Occlusion Percutaneous Coronary Intervention (CTO PCI)

> **NCT05259241** · NA · UNKNOWN · sponsor: **Erasmus Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- Transcatheter Aortic Valve Replacement
- Percutaneous Coronary Intervention

## Interventions

- **DIAGNOSTIC_TEST:** activated partial thrombin time

## Key facts

- **NCT ID:** NCT05259241
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-20
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-01-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05259241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05259241, "ADAPT Transcatheter Aortic Valve Intervention (TAVI & Chronic Total Occlusion Percutaneous Coronary Intervention (CTO PCI)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05259241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*